B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PTGIR

MOLECULAR TARGET

prostaglandin I2 receptor

UniProt: P43119NCBI Gene: 57394 compounds

PTGIR (prostaglandin I2 receptor) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PTGIR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Iloprost2.8917
2Alprostadil2.208
3Dinoprostone1.102
4Epoprostenol0.691

About PTGIR as a Drug Target

PTGIR (prostaglandin I2 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented PTGIR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PTGIR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.